外科理论与实践

外科理论与实践 >

2022 , Vol. 27 >Issue 06: 511 - 516

DOI: https://doi.org/10.16139/j.1007-9610.2022.06.06

专家论坛

影像学检查在腹膜后肿瘤诊治中的应用及相关专家共识解读

展开
  • a.复旦大学附属中山医院 放射科 上海市影像医学研究所，上海 200032
    b.复旦大学附属中山医院 核医学科，上海 200032
    c.复旦大学附属中山医院 超声科，上海 200032

收稿日期: 2022-09-13

  网络出版日期: 2023-01-30

收起

Imaging in diagnosis and treatment of retroperitoneal tumor: application and expert consensus interpretation

Expand

Received date: 2022-09-13

  Online published: 2023-01-30

Fold

本文引用格式

丁玉芹, 石洪成, 季正标 . 影像学检查在腹膜后肿瘤诊治中的应用及相关专家共识解读[J]. 外科理论与实践, 2022 , 27(06) : 511 -516 . DOI: 10.16139/j.1007-9610.2022.06.06

参考文献

[1] Swallow CJ, Strauss DC, Bonvalot S, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group[J]. Ann Surg Oncol, 2021, 28(12):7873-7888.
[2] 中华医学会肿瘤学分会, 中华医学会杂志社, 中国医师协会肛肠医师分会腹膜后疾病专业委员会, 等. 中国腹膜后肿瘤诊治专家共识(2019版)[J]. 中华肿瘤杂志, 2019, 41(10):728-733.
[3] Rajiah P, Sinha R, Cuevas C, et al. Imaging of uncommon retroperitoneal masses[J]. Radiographics, 2011, 31(4):949-976.
[4] Gupta P, Potti TA, Wuertzer SD, et al. Spectrum of fat-containing soft-tissue masses at MR imaging: the common, the uncommon, the characteristic, and the sometimes confusing[J]. Radiographics, 2016, 36(3):753-766.
[5] Shaaban AM, Rezvani M, Tubay M, et al. Fat-containing retroperitoneal lesions: imaging characteristics, localization, and differential diagnosis[J]. Radiographics, 2016, 36(3):710-734.
[6] Marko J, Wolfman DJ. Retroperitoneal leiomyosarcoma from the radiologic pathology archives[J]. Radiographics, 2018, 38(5):1403-1420.
[7] Sun J, Yu XR, Shi BB, et al. CT features of retroperitoneal solitary fibrous tumor: report of three cases and review of the literature[J]. World J Surg Oncol, 2014, 12:324.
[8] Keraliya AR, Tirumani SH, Shinagare AB, et al. Solitary fibrous tumors: 2016 imaging update[J]. Radiol Clin North Am, 2016, 54(3):565-579.
[9] Petscavage-Thomas JM, Walker EA, Logie CI, et al. Soft-tissue myxomatous lesions: review of salient imaging features with pathologic comparison[J]. Radiographics, 2014, 34(4):964-980.
[10] Lefkowitz RA, Landa J, Hwang S, et al. Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging[J]. Skeletal Radiol, 2013, 42(6):809-818.
[11] Banks KP. The target sign: extremity[J]. Radiology, 2005, 234(3):899-900.
[12] Stramare R, Beltrame V, Gazzola M, et al. Imaging of soft-tissue tumors[J]. J Magn Reson Imaging, 2013, 37(4):791-804.
[13] Pilavaki M, Chourmouzi D, Kiziridou A, et al. Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review[J]. Eur J Radiol, 2004, 52(3):229-239.
[14] Rha SE, Byun JY, Jung SE, et al. Neurogenic tumors in the abdomen: tumor types and imaging characteristics[J]. Radiographics, 2003, 23(1):29-43.
[15] Zhang Y, Nishimura H, Kato S, et al. MRI of ganglioneuroma: histologic correlation study[J]. J Comput Assist Tomogr, 2001, 25(4):617-623.
[16] Lee KY, Oh YW, Noh HJ, et al. Extraadrenal paragangliomas of the body: imaging features[J]. Am J Roentgenol, 2006, 187(2):492-504.
[17] Janssen I, Chen CC, Millo CM, et al. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(10):1784-1791.
[18] Kitajima K, Kono A, Konishi J, et al. 18F-FDG-PET/CT findings of retroperitoneal tumors: a pictorial essay[J]. Jpn J Radiol, 2013, 31(5):301-309.
[19] Atri M, Zhang Z, Dehdashti F, et al. Utility of PET/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671/GOG 0233 trial[J]. Radiology, 2017, 283(2):450-459.
[20] Subramaniam S, Callahan J, Bressel M, et al. The role of 18F-FDG PET/CT in retroperitoneal sarcomas—a multicenter retrospective study[J]. J Surg Oncol, 2021, 123(4):1081-1087.
[21] Fernando A, Pattison J, Horsfield C, et al. 18F-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study[J]. Eur Urol, 2017, 71(6):926-933.
[22] Lim CH, Seok HY, Hyun SH, et al. Evaluation of a diagnostic 18F-FDG PET/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses[J]. Clin Radiol, 2019, 74(3):207-215.
[23] Costa LB, Queiroz MA, Barbosa FG, et al. Reassessing patterns of response to immunotherapy with PET: from morphology to metabolism[J]. Radiographics, 2021, 41(1):120-143.
[24] 谢琉嘉, 徐亚丹, 闻捷先, 等. 超声造影引导下经皮腹膜后占位性病变穿刺活检的价值[J]. 肿瘤影像学, 2019, 28(6):365-370.
[25] Leahy S, Fang AM, Banks C, et al. Intravascular ultrasound for the evaluation and management of retroperitoneal, genitourinary malignancies[J]. Curr Urol Rep, 2022, 23(5):67-73.
[26] Hannesson PH, Lundstedt C, Dawiskiba S, et al. Transhepatic intravascular ultrasound for evaluation of portal venous involvement in patients with cancer of the pancreatic head region[J]. Eur Radiol, 2002, 12(5):1150-1154.
[27] 王成刚, 龚高全. 介入技术在腹膜后肿瘤临床诊疗中的应用进展[J]. 中国临床医学, 2021, 28(2):323-327.
[28] 彭梦凡, 李玉燕, 齐清华, 等. 超声引导射频消融治疗腹膜后肿瘤的临床价值[J]. 中华肿瘤杂志, 2022, 44(5):442-445.
Options
文章导航

/

〈 〉